{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-048405","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2023-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.211409+00:00","generated_at":"2026-06-16T21:26:10.523937+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NRX Pharma receives Nasdaq bid price deficiency notice; sues to unmask short attackers","bullets":["Nasdaq notice on April 18, 2023: closing bid below $1.00 for 30 consecutive business days.","Company has 180 days (until Oct 16, 2023) to regain compliance; needs $1.00+ close for 10 days.","Filed NY State Supreme Court lawsuit to compel disclosure of identities posting false, derogatory info.","Commissioned expert counsel to assess impact of naked shorting and spoofing on stock.","Confirms strategic licensing discussions remain ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-048405","json":"https://secwatch.observer/filing/0001104659-23-048405.json","markdown":"https://secwatch.observer/filing/0001104659-23-048405.md","text":"https://secwatch.observer/filing/0001104659-23-048405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000110465923048405/0001104659-23-048405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000110465923048405/tm2313427d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T21:26:10.523937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e8d5e7d356100ad625579f9d85dac2c796ea548f","claim":"NRX Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).","evidence_excerpt":"April 18, 2023, the Company received a written notification (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Registrant was not in compliance with Nasdaq Listing Rule 5450(a)(1), as the Registrant’s closing bid price for its common stock was below $1.00 per share for the last thirty (30) consecutive business days. Nasdaq’s notice has no immediate effect on the listing of the common stock on The Nasdaq Global Market and, at this time, the common stock will continue to trade on The Nasdaq Global Market under the symbol “NRXP”. Pursuant to Nasdaq Listing Rule 5810(c)","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1719406/000110465923048405/0001104659-23-048405-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}